KYMR - Company ID 0001815442
Kymera Therapeutics, Inc. has filed 575 public company documents between 2020 and 2026. The most frequent type is insider trade (238 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Type | Filing | Filed | Period covered | Open |
|---|---|---|---|---|
| SCHEDULE 13D/A | SCHEDULE 13D/A | 1y ago2025-06-30 | - | View filing |
| 4 | Insider trade | 1y ago2025-06-30 | 2025-06-30 | View filing |
| 8-K | Major company event | 1y ago2025-06-27 | 2025-06-25 | View filing |
| 8-K | Major company event | 1y ago2025-06-27 | 2025-06-25 | View filing |
| 424B5 | Prospectus supplement | 1y ago2025-06-27 | - | View filing |
| 4 | Insider trade | 1y ago2025-06-26 | 2025-06-25 | View filing |
| 4 | Insider trade | 1y ago2025-06-26 | 2025-06-25 | View filing |
| 4 | Insider trade | 1y ago2025-06-26 | 2025-06-25 | View filing |
| 4 | Insider trade | 1y ago2025-06-26 | 2025-06-25 | View filing |
| 4 | Insider trade | 1y ago2025-06-26 | 2025-06-25 | View filing |
| 4 | Insider trade | 1y ago2025-06-26 | 2025-06-25 | View filing |
| 4 | Insider trade | 1y ago2025-06-26 | 2025-06-25 | View filing |
| 4 | Insider trade | 1y ago2025-06-26 | 2025-06-25 | View filing |
| 424B5 | Prospectus supplement | 1y ago2025-06-25 | - | View filing |
| 8-K | Major company event | 1y ago2025-06-25 | 2025-06-25 | View filing |
| 8-K | Major company event | 1y ago2025-06-25 | 2025-06-25 | View filing |
| 144 | Insider sale notice | 1y ago2025-06-11 | - | View filing |
| 4 | Insider trade | 1y ago2025-06-11 | 2025-06-11 | View filing |
| 144 | Insider sale notice | 1y ago2025-06-03 | - | View filing |
| 144 | Insider sale notice | 1y ago2025-06-03 | - | View filing |
| 144 | Insider sale notice | 1y ago2025-06-03 | - | View filing |
| 144 | Insider sale notice | 1y ago2025-06-03 | - | View filing |
| 4 | Insider trade | 1y ago2025-06-03 | 2025-06-03 | View filing |
| 4 | Insider trade | 1y ago2025-06-03 | 2025-06-03 | View filing |
| 4 | Insider trade | 1y ago2025-06-03 | 2025-06-03 | View filing |
| 4 | Insider trade | 1y ago2025-06-03 | 2025-06-03 | View filing |
| 8-K | Major company event | 1y ago2025-06-02 | 2025-06-02 | View filing |
| 8-K | Major company event | 1y ago2025-06-02 | 2025-06-02 | View filing |
| 4 | Insider trade | 1y ago2025-05-23 | 2025-05-23 | View filing |
| 144 | Insider sale notice | 1y ago2025-05-23 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 1y ago2025-05-12 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 1y ago2025-05-12 | - | View filing |
| 8-K | Major company event | 1y ago2025-05-09 | 2025-05-09 | View filing |
| 10-Q | Quarterly report | 1y ago2025-05-09 | 2025-03-31 | View filing |
| UPLOAD | SEC correspondence | 1y ago2025-05-07 | - | View filing |
| CORRESP | Company correspondence | 1y ago2025-04-30 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 1y ago2025-04-30 | - | View filing |
| ARS | Annual report to shareholders | 1y ago2025-04-29 | 2024-12-31 | View filing |
| DEFA14A | Proxy materials | 1y ago2025-04-29 | - | View filing |
| DEF 14A | Proxy statement | 1y ago2025-04-29 | 2025-06-25 | View filing |
| UPLOAD | SEC correspondence | 1y ago2025-04-25 | - | View filing |
| 4 | Insider trade | 1y ago2025-04-09 | 2025-04-08 | View filing |
| 3 | New insider ownership | 1y ago2025-04-09 | 2025-04-08 | View filing |
| 4 | Insider trade | 1y ago2025-04-01 | 2025-03-31 | View filing |
| 8-K | Major company event | 1y ago2025-03-03 | 2025-03-03 | View filing |
| 4 | Insider trade | 1y ago2025-03-03 | 2025-03-03 | View filing |
| 4 | Insider trade | 1y ago2025-03-03 | 2025-03-03 | View filing |
| 4 | Insider trade | 1y ago2025-03-03 | 2025-03-03 | View filing |
| 4 | Insider trade | 1y ago2025-03-03 | 2025-03-03 | View filing |
| 4 | Insider trade | 1y ago2025-03-03 | 2025-03-03 | View filing |